Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006)
Authors:
Open Access
- 28 October 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 65 (1) , 148-155
Abstract
To assess provincial-level predictors among socioeconomic and influenza rate data for the use of different macrolide antimicrobials in Canada from 2000 to 2006. Multivariable models were developed to describe macrolide defined daily doses per capita. Use was highest during October to March for all macrolides. Investigated yearly and provincial patterns differed considerably among the macrolide agents. Associations with socioeconomic variables were similar between clarithromycin and erythromycin, while azithromycin consumption showed some differences in its association with these variables. Consistently, the rate of influenza was significantly associated with increased macrolide use. The influenza rate interacted with socioeconomic variables in some models; as the influenza rate increased, the greatest increase in demand for macrolides occurred in populations with high percentages of low-income individuals, high unemployment levels and low percentages of individuals with bachelor's degrees. The impact of associations among macrolide consumption, influenza and socioeconomic factors may reflect inappropriate use of these agents to treat viral infections and/or prescribing for secondary infections, and knowledge of the virus versus bacteria problem and accessibility of healthcare. Further research surrounding differences in access to antimicrobial prescriptions and treatment options between advantaged and disadvantaged populations is suggested to further understand the dynamics of antimicrobial use in Canada.Keywords
This publication has 21 references indexed in Scilit:
- Predictors of inappropriate antibiotic prescribing among primary care physiciansCanadian Medical Association Journal, 2007
- European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in EuropeJournal of Antimicrobial Chemotherapy, 2006
- Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Increased Use of Second-Generation Macrolide Antibiotics for Children in Nine Health Plans in the United StatesPediatrics, 2004
- Decrease in antibiotic use among children in the 1990s: not all antibiotics, not all childrenCanadian Medical Association Journal, 2004
- Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in SpainJournal of Antimicrobial Chemotherapy, 2004
- Changes in the Prevalence of Vancomycin‐Resistant Enterococci in Response to Antimicrobial Formulary Interventions: Impact of Progressive Restrictions on Use of Vancomycin and Third‐Generation CephalosporinsClinical Infectious Diseases, 2003
- Importance of Local Variations in Antibiotic Consumption and Geographical Differences of Erythromycin and Penicillin Resistance in Streptococcus pneumoniaeJournal of Clinical Microbiology, 2002
- Excessive Antibiotic Use for Acute Respiratory Infections in the United StatesClinical Infectious Diseases, 2001
- Antibiotic Prescribing by Pediatricians for Respiratory Tract Infection in ChildrenClinical Infectious Diseases, 1999